secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-09-18T23:59:59+00:00
Accession:  0000950170-24-107776
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo raises $3.0M via registered direct offering of stock and warrants at $0.33/share
--------------------------------------------------------------------------------

- Issued 9,090,910 shares or pre-funded warrants plus warrants for up to 18,181,820 shares at $0.33 per unit.
- Gross proceeds ~$3.0M; net proceeds ~$2.5M after fees; proceeds for clinical development and working capital.
- Existing warrants covering 11,822,774 shares amended to reduce exercise price from $0.515 to $0.33 per share.
- Warrants are exercisable upon stockholder approval and expire five years thereafter; closing occurred September 18, 2024.
- Roth Capital Partners acted as exclusive placement agent; 7.0% cash fee on gross proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024107776/0000950170-24-107776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024107776/apvo-20240916.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-107776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer